EQS-News: Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds
Retrieved on:
Tuesday, October 17, 2023
Perception, Max Planck Society, Hope, Plasma, LKH, KAP, Trial of the century, Education, PH, Synthetic control method, Wound healing, Morfill, Gesellschaft mit beschränkter Haftung, Supervisory board, Research, Publication, SWT, Skin, VAS, Max Planck Institute for Nuclear Physics, Observation, Healing, Patient, Quality of life, Federal Ministry of Health (Germany), Nursing, Pain
Hamburg / Munich - 06.10.2023 - For people with chronic and non-healing wounds, there is a solution: cold atmospheric plasma (KAP).
Key Points:
- Hamburg / Munich - 06.10.2023 - For people with chronic and non-healing wounds, there is a solution: cold atmospheric plasma (KAP).
- As proven by a pilot study commissioned by Munich-based terraplasma medical GmbH, a company of the Hamburg-based Viromed Group, the innovative wound and skin treatment of the cold plasma technique is superior to standard wound treatment (SWT).
- The study used the mobile, CE-certified and painless cold plasma device plasma care® from terraplasma medical.
- The aim of treating (infected) chronic and acute wounds with KAP is to inactivate microorganisms, including multi-resistant pathogens, and to stimulate wound healing.